Genmab reported its Second Quarter 2014 financial results and held an investor conference call on August 13. Click the following links to access the archived call: listen to the webcast; download the podcast; download the slide presentation.
Genmab's CEO shares his perspective on how the company's work to develop innovative antibody therapeutics could change the lives of cancer patients in the future. Click here to watch the video.
Genmab is inviting researchers in academia and industry to experience the full power of the DuoBody® platform for bispecific antibody research and drug development. Explore the possibilities via our recently published Perspective in the journal mAbs and the renewed Open Innovation section on DuoBody.com.